Opinionated Science Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials
Podcast Jun 05, 2020
Opinionated Science is Technology Networks’ homemade podcast, where our team of scientists-turned-journalists cut out the chewy jargon and serve up slices of the most fascinating stories from the world of science. Expect a new Opinionated Science every other Friday.
In this episode, the Technology Networks team discuss drug treatments to combat SARS-CoV-2. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic?
Read more from this podcast:
Hydroxychloroquine Revived by WHO
How modeling can support drug development
Covid-19 brings drug development to a halt
Tackling Covid-19: ongoing drug development efforts
Flooded by the torrent: the COVID-19 drug pipeline
Global impact on clinical trials
What is a preprint?
Exploring the drug development process
Keep up to date with COVID-19 vaccine development
Hydroxychloroquine arm stopped in RECOVERY Trial
Listen to more Technology Networks podcasts here.
Subscribe to Opinionated Science at your favorite podcast platform: